Antibiotice Iaşi posted a 25% increase in profit after the first quarter of 2020

The Romanian drug manufacturer Antibiotice Iaşi posted a net profit increasing by 25% after the first three months of this year, to 4.08 million lei, due to the tax exemption facility for the profit invested in technological equipment, it is shown in a communiqué of the company sent on Tuesday to the Bucharest Stock Exchange. The operating profit increased, on March 31, by 6%, to 5.45 million lei, from 5.17 million lei, in the similar period of last year.

https://www.agerpres.ro/economic-intern/2020/05/12/antibiotice-iasi-a-afisat-un-profit-in-crestere-cu-25-dupa-primul-trimestru-din-2020–504066